Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
editorial
. 1995 Nov;74(5):479–480. doi: 10.1136/hrt.74.5.479

Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy.

C M Oakley
PMCID: PMC484064  PMID: 8562229

Full text

PDF
479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRAUNWALD E., LAMBREW C. T., ROCKOFF S. D., ROSS J., Jr, MORROW A. G. IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS. I. A DESCRIPTION OF THE DISEASE BASED UPON AN ANALYSIS OF 64 PATIENTS. Circulation. 1964 Nov;30:SUPPL 4–119. doi: 10.1161/01.cir.29.5s4.iv-3. [DOI] [PubMed] [Google Scholar]
  2. Beahrs M. M., Tajik A. J., Seward J. B., Giuliani E. R., McGoon D. C. Hypertrophic obstructive cardiomyopathy: ten- to 21-year follow-up after partial septal myectomy. Am J Cardiol. 1983 Apr;51(7):1160–1166. doi: 10.1016/0002-9149(83)90363-6. [DOI] [PubMed] [Google Scholar]
  3. Blanchard D. G., Ross J., Jr Hypertrophic cardiomyopathy: prognosis with medical or surgical therapy. Clin Cardiol. 1991 Jan;14(1):11–19. doi: 10.1002/clc.4960140105. [DOI] [PubMed] [Google Scholar]
  4. Brezinski D. A., Tofler G. H., Muller J. E., Pohjola-Sintonen S., Willich S. N., Schafer A. I., Czeisler C. A., Williams G. H. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation. 1988 Jul;78(1):35–40. doi: 10.1161/01.cir.78.1.35. [DOI] [PubMed] [Google Scholar]
  5. CLELAND W. P. THE SURGICAL MANAGEMENT OF OBSTRUCTIVE CARDIOMYOPATHY. J Cardiovasc Surg (Torino) 1963 Aug;4:489–491. [PubMed] [Google Scholar]
  6. COHEN J., EFFAT H., GOODWIN J. F., OAKLEY C. M., STEINER R. E. HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY. Br Heart J. 1964 Jan;26:16–32. doi: 10.1136/hrt.26.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chahine R. A. Surgical versus medical therapy of hypertrophic cardiomyopathy: is the perspective changing? J Am Coll Cardiol. 1991 Mar 1;17(3):643–645. doi: 10.1016/s0735-1097(10)80177-9. [DOI] [PubMed] [Google Scholar]
  8. Criley J. M., Lewis K. B., White R. I., Jr, Ross R. S. Pressure gradients without obstruction. A new concept of "hypertrophic subaortic stenosis". Circulation. 1965 Dec;32(6):881–887. doi: 10.1161/01.cir.32.6.881. [DOI] [PubMed] [Google Scholar]
  9. Delahaye F., Jegaden O., de Gevigney G., Genoud J. L., Perinetti M., Montagna P., Delaye J., Mikaeloff P. Postoperative and long-term prognosis of myotomy-myomectomy for obstructive hypertrophic cardiomyopathy: influence of associated mitral valve replacement. Eur Heart J. 1993 Sep;14(9):1229–1237. doi: 10.1093/eurheartj/14.9.1229. [DOI] [PubMed] [Google Scholar]
  10. Fananapazir L., Epstein N. D., Curiel R. V., Panza J. A., Tripodi D., McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation. 1994 Dec;90(6):2731–2742. doi: 10.1161/01.cir.90.6.2731. [DOI] [PubMed] [Google Scholar]
  11. Fananapazir L., Epstein N. D. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation. 1994 Jan;89(1):22–32. doi: 10.1161/01.cir.89.1.22. [DOI] [PubMed] [Google Scholar]
  12. Fay W. P., Taliercio C. P., Ilstrup D. M., Tajik A. J., Gersh B. J. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol. 1990 Oct;16(4):821–826. doi: 10.1016/s0735-1097(10)80328-6. [DOI] [PubMed] [Google Scholar]
  13. GOODWIN J. F., HOLLMAN A., CLELAND W. P., TEARE D. Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J. 1960 Jun;22:403–414. doi: 10.1136/hrt.22.3.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hassenstein P., Walther H., Dittrich J. Hämodynamische Veränderungen durch einfache und gekoppelte Stimulation bei Patienten mit obstruktiver Kardiomyopathie. Verh Dtsch Ges Inn Med. 1975;81:170–173. [PubMed] [Google Scholar]
  15. Isner J. M., Clarke R. H., Pandian N. G., Donaldson R. F., Salem D. N., Konstam M. A., Payne D. D., Cleveland R. J. Laser myoplasty for hypertrophic cardiomyopathy. In vitro experience in human postmortem hearts and in vivo experience in a canine model (transarterial) and human patient (intraoperative). Am J Cardiol. 1984 Jun 1;53(11):1620–1625. doi: 10.1016/0002-9149(84)90590-3. [DOI] [PubMed] [Google Scholar]
  16. Jeanrenaud X., Goy J. J., Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 1992 May 30;339(8805):1318–1323. doi: 10.1016/0140-6736(92)91961-7. [DOI] [PubMed] [Google Scholar]
  17. Kofflard M. J., Waldstein D. J., Vos J., ten Cate F. J. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol. 1993 Oct 15;72(12):939–943. doi: 10.1016/0002-9149(93)91111-t. [DOI] [PubMed] [Google Scholar]
  18. Leachman R. D., Krajcer Z., Azic T., Cooley D. A. Mitral valve replacement in hypertrophic cardiomyopathy: ten-year follow-up in 54 patients. Am J Cardiol. 1987 Dec 1;60(16):1416–1418. doi: 10.1016/0002-9149(87)90637-0. [DOI] [PubMed] [Google Scholar]
  19. MORROW A. G., BRAUNWALD E. Functional aortic stenosis; a malformation characterized by resistance to left ventricular outflow without anatomic obstruction. Circulation. 1959 Aug;20(2):181–189. doi: 10.1161/01.cir.20.2.181. [DOI] [PubMed] [Google Scholar]
  20. Maron B. J., Epstein S. E., Roberts W. C. Causes of sudden death in competitive athletes. J Am Coll Cardiol. 1986 Jan;7(1):204–214. doi: 10.1016/s0735-1097(86)80283-2. [DOI] [PubMed] [Google Scholar]
  21. McDonald K., McWilliams E., O'Keeffe B., Maurer B. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J. 1988 Aug;9(8):893–898. doi: 10.1093/oxfordjournals.eurheartj.a062584. [DOI] [PubMed] [Google Scholar]
  22. McIntosh C. L., Greenberg G. J., Maron B. J., Leon M. B., Cannon R. O., 3rd, Clark R. E. Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 1989 Feb;47(2):236–246. doi: 10.1016/0003-4975(89)90277-4. [DOI] [PubMed] [Google Scholar]
  23. Morrow A. G. Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg. 1978 Oct;76(4):423–430. [PubMed] [Google Scholar]
  24. Romeo F., Pelliccia F., Cristofani R., Martuscelli E., Reale A. Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J. 1990 Mar;11(3):233–240. doi: 10.1093/oxfordjournals.eurheartj.a059689. [DOI] [PubMed] [Google Scholar]
  25. Seiler C., Hess O. M., Schoenbeck M., Turina J., Jenni R., Turina M., Krayenbuehl H. P. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol. 1991 Mar 1;17(3):634–642. doi: 10.1016/s0735-1097(10)80176-7. [DOI] [PubMed] [Google Scholar]
  26. Shapiro L. M., Zezulka A. Hypertrophic cardiomyopathy: a common disease with a good prognosis. Five year experience of a district general hospital. Br Heart J. 1983 Dec;50(6):530–533. doi: 10.1136/hrt.50.6.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995 Jul 22;346(8969):211–214. doi: 10.1016/s0140-6736(95)91267-3. [DOI] [PubMed] [Google Scholar]
  28. Spirito P., Chiarella F., Carratino L., Berisso M. Z., Bellotti P., Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989 Mar 23;320(12):749–755. doi: 10.1056/NEJM198903233201201. [DOI] [PubMed] [Google Scholar]
  29. Spirito P., Maron B. J., Bonow R. O., Epstein S. E. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol. 1987 Jul 1;60(1):123–129. doi: 10.1016/0002-9149(87)90998-2. [DOI] [PubMed] [Google Scholar]
  30. TEARE D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958 Jan;20(1):1–8. doi: 10.1136/hrt.20.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. WIGLE E. D., HEIMBECKER R. O., GUNTON R. W. Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation. 1962 Sep;26:325–340. doi: 10.1161/01.cir.26.3.325. [DOI] [PubMed] [Google Scholar]
  32. Walker W. S., Reid K. G., Cameron E. W., Walbaum P. R., Kitchin A. H. Comparison of ventricular septal surgery and mitral valve replacement for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 1989 Oct;48(4):528–535. doi: 10.1016/s0003-4975(10)66855-5. [DOI] [PubMed] [Google Scholar]
  33. al-Mahdawi S., Chamberlain S., Chojnowska L., Michalak E., Nihoyannopoulos P., Ryan M., Kusnierczyk B., French J. A., Gilligan D. M., Cleland J. The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J. 1994 Aug;72(2):105–111. doi: 10.1136/hrt.72.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES